Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
Marjory Koller, Si-Qi Qiu, Matthijs D. Linssen and 10 more
Nature Communications · 2018
doi:10.1038/s41467-018-05727-y (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Fluorescent tracers are being tested in clinical trials to improve detection of tumor margins, but procedures are not standardised. Here, the authors develop an analytical framework that is compatible with the workflow in the operating theatre, and show that it leads to an 88% increase in intraoperative detection of tumor margins in patients with breast cancer.
Abstract licence: CC BY-NC-ND
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.